HIV Genetic Networks and Drug Resistance Surveillance in Mexico

Santiago Avila-Ríos, PhD

Researcher in Medical Sciences, Centre for Research in Infectious Diseases (CIENI) of the National Institute of Respiratory Diseases (INER), Mexico City, Mexico

Dr. Santiago Avila-Ríos is a researcher in medical sciences at the Centre for Research in Infectious Diseases (CIENI) of the National Institute of Respiratory Diseases (INER) in Mexico City and a member of Mexico’s National Researchers System (SNI-II).

He received his first degree on Pharmaceutical Chemistry from the National Autonomous University of Mexico (UNAM), in Mexico City; his MSc degree on Molecular Medical Microbiology from the Nottingham University, Nottingham, UK; and his PhD degree on Biomedical Sciences from the UNAM.

At the moment, Santiago Avila-Rios conducts research on HIV molecular epidemiology, transmitted drug resistance surveillance and HLA-associated evolution in the Mesoamerican Region. He also coordinates the participation of the CIENI/INER as a WHO Regional Reference Laboratory for the Technical Cooperation Network for HIV Drug Resistance for Latin America and the Caribbean. He directly coordinates de Molecular Biology Laboratory of the CIENI/INER, mainly focused on Sanger and next generation sequencing. He authored or co-authored more than 40 peer reviewed articles and has been tutor of more than ten undergraduate and five postgraduate students.


This is a free lecture and is open to the public. The lectures are geared towards researchers, clinicians, students and hospital staff.

Eventbrite - Forefront Lectures

For more information, please contact education@cfenet.ubc.ca / local 66255



Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below